Phage therapy explained: Regulatory pathways for phage cocktails
The potential of bacteriophages to tackle both conventional and antibiotic-resistant bacterial infections is becoming more widely recognised.
The potential of bacteriophages to tackle both conventional and antibiotic-resistant bacterial infections is becoming more widely recognised.
NexaBiome Life Sciences LTD is developing phages as human pharmaceuticals.
Antimicrobial Resistance (AMR) represents one of the top pressing global health threats, as ranked by the World Health Organization (WHO).
Diabetic foot infections (DFIs) are a serious and often overlooked complication of diabetes, affecting up to a third of all diabetic patients globally.